Panacea Biotec gets UDFDA approval for supply of Azacitidine Injection to US market
Panacea Biotec's Oncology Parenteral Formulation Facility at Baddi,
Himachal Pradesh, India, received United States Food & Drug Administration (USFDA) approval
for manufacture and supply of Azacitidine Injection, 100 mg/vial, for the US market.
Panacea Biotec's state-of-the-art pharmaceutical formulation facility at Baddi is already approved by National Regulatory Authority (NRA) of India and USFDA for other oral solids and injectable products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: May 20 2019 | 6:56 PM IST